PUBLISHER: The Business Research Company | PRODUCT CODE: 1241315
PUBLISHER: The Business Research Company | PRODUCT CODE: 1241315
Contact us about how to customize the report with add-on data.
“Home Infusion Therapy Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on home infusion therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for home infusion therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The home infusion therapy market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
* The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
* The impact of higher inflation in many countries and the resulting spike in interest rates.
* The continued but declining impact of COVID-19 on supply chains and consumption patterns.
Major players in the home infusion therapy market are: B Braun Melsungen AG, Baxter International Inc., Eli Lilly and Company, Fresenius Kabi, Option Care Health Inc., CareCentrix Inc., Caesarea Medical Electronics, JMS Co.Ltd., Terumo Corporation, Smiths Medica, Optum Inc., CVS Health, KabaFusion, PromptCare, and Nipro Corporation.
The global home infusion therapy market grew from $24.99 billion in 2022 to $27.93 billion in 2023 at a compound annual growth rate (CAGR) of 11.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The home infusion therapy market is expected to grow to $40.52 billion in 2027 at a CAGR of 9.7%.
The home infusion therapy market includes revenues earned by entities anti-emetics, catheter maintenance, chemotherapy, hydration, immune globulin therapy, and inotropic therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Home infusion therapy is a process of subcutaneous or intravenous administration of biologicals or drugs to a person at home. Patients can receive medications through catheters or needles, directly into their veins or under their skin. The home infusion therapy are used to treat individuals at home.
North America was the largest region in the home infusion therapy market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the home infusion therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The main types of products in home infusion therapy are infusion pumps, intravenous sets, IV cannulas, and needleless connectors. Home infusion pumps are medical devices that deliver medicine into the patient's body in specific, controlled amounts. It controls the rate of replacement fluid infused into the blood outflow line or the blood inflow line. The different administrations include intramuscular, subcutaneously, and epidural that are used in numerous applications such as total parenteral nutrition, anti-infective therapy, enteral nutrition, hydration therapy, chemotherapy, IVIg or specialty pharmaceuticals, and other applications. The several end users include patients, nurses, hospitals, and others.
The increasing population and consequent rise in food demand are expected to propel the growth of the home infusion therapy market moving forward. Food refers to the substance consisting of protein, carbohydrates, fat, and other nutrients that are used in the body of an organism for sustaining growth and vital processes and furnishing energy. Food is the essential factor for the patients undergoing home infusion therapy, and the increasing population led to an increase in the number of aged people who require home infusion therapy. For instance, according to United Nations data, the world's population has been expected to increase by 2 billion people in the next 30 years, from 7.7 billion currently to 9.7 billion in 2050. Moreover, according to Intechnopen data, a London-based journal website, the global demand for food has been expected to increase by 70% by 2050. Therefore, the increasing population and consequent rise in food demand will drive the growth of the home infusion therapy market.
Strategic partnerships and collaborations have emerged as the key trend gaining popularity in the home infusion therapy market. Major companies operating in the home infusion therapy sector are focused on partnerships to reinforce their position in the market. For instance, in April 2022, CarepathRx, a US-based pharmacy, and medication management solutions, partnered with Mount Sinai Health System, a US-based hospital network. This partnership allows expanding patient access to home infusion therapies across the Mount Sinai Health System, encompassing its eight hospitals and ambulatory footprint. Furthermore, in December 2021, CarepathRx, a US-based pharmacy, and medication management solutions, partnered with the University of Chicago Medicine (UChicago Medicine), a US-based academic medical center. This partnership allows CarepathRx to provide comprehensive home and specialty infusion services to the academic health system's growing patient population. It also helps UChicago Medicine to extend its clinical reach into the home and ambulatory setting.
In March 2021, PromptCare, a US-based specialty home infusion, and complex respiratory services company acquired NBN Infusions Inc., for an undisclosed amount. Through this acquisition, PromptCare aims at strengthening its focus on providing specialty infusion therapies. NBN Infusions Inc is a US-based provider of health care services including home infusion therapy, enteral therapy, and respiratory therapy services.
The countries covered in the home infusion therapy market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The home infusion therapy market research report is one of a series of new reports from The Business Research Company that provides home infusion therapy market statistics, including home infusion therapy industry global market size, regional shares, competitors with a home infusion therapy market share, detailed home infusion therapy market segments, market trends and opportunities, and any further data you may need to thrive in the home infusion therapy industry. This home infusion therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.